Straits Times Index
3,205.14 +16.64 (+0.52%) Nikkei
28,804.85 +96.27 (+0.34%) Hang Seng
26,126.93 +109.40 (+0.42%) FTSE 100
7,204.55 +14.25 (+0.20%) BTC-USD
61,131.00 +348.55 (+0.57%) CMC Crypto 200
1,453.34 -49.69 (-3.31%)
Inovio Pharmaceuticals, Inc. (INO)
After hours: 07:59PM EDT
- Motley Fool
4 Growth Stocks With 187% to 434% Upside, According to Wall Street
Based on analysts' loftiest price targets, these companies could nearly triple or potentially quintuple investors' money over the next year.
- Motley Fool
Is This The Turning Point for Inovio?
It seems such a long time ago that Inovio Pharmaceuticals (NASDAQ: INO) was considered one of the leaders in the hunt for a COVID-19 vaccine -- but the biotech was left in the dust by peers and many investors have given up on the stock. In the past 12 months, shares of Inovio are down 45% even as the broader market took off. Let's see whether the company is finally ready to turn things around.
- Motley Fool
5 Stocks With 195% to 467% Upside, According to Wall Street
If the high-water price target for each of the following five stocks were to come to fruition, shareholders would be looking at gains ranging from a low of 195% to as much as 467%. If you're "only" looking to triple your money, analyst Amit Dayal of H.C. Wainwright would suggest putting it to work in hydrogen fuel-cell solutions company Plug Power (NASDAQ: PLUG). Dayal's price target of $78 implies a cool 195% upside from where its shares closed this past weekend.
